Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04407754 · ClinicalTrials.gov registry record · NA

Myo-Inositol for Infertility in PCOS

A NA study of Polycystic Ovary Syndrome, sponsored by University of Oklahoma.

Recruiting
Registry status
NA
Development phase
168
Enrollment target
1
Study location

NCT04407754: Recruiting NA study of Polycystic Ovary Syndrome, sponsored by University of Oklahoma.

NCT04407754 is a NA study of Polycystic Ovary Syndrome that is actively recruiting participants, run by University of Oklahoma. The registered enrollment target is 168 participants, below the 17,252-participant average among 30 other Polycystic Ovary Syndrome trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04407754, a NA study of Polycystic Ovary Syndrome, is actively recruiting participants, sponsored by University of Oklahoma.

RECRUITING
Registry status
NA
Development phase
168 participants
Enrollment target
1
Study location

Study Summary

This will be a prospective, double-blind randomized clinical trial of letrozole and placebo versus letrozole and inositols for up to 5 treatment cycles of ovulation induction or until pregnancy is achieved. All participants and members of the research team will be blinded to the treatment arms. Placebo and inositol supplement will be packaged to appear the same, tested, and packaged by a commercial supply company. The inositols will be a 40:1 blend of myo-inositol and D-chiro inositol.

Primary Outcome

Clinical pregnancy will be defined as documentation of a viable intrauterine pregnancy as noted by visualization of fetal heart motion on ultrasonography.

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT Inositol supplement
  • DIETARY_SUPPLEMENT Placebo supplement

Study Locations (1)

Oklahoma

  • OUHSC Reproductive Medicine Clinic - Oklahoma City

Trial Details

FieldValue
Enrollment Target 168 participants
Start Date 2022-02-07
Est. Completion 2026-02
Phase NA
University of Oklahoma

358 total trials

What NCT04407754 shows while recruiting

NCT04407754 is an interventional study that assigns participants to a tested intervention. The registered 168 participants enrollment target is mid-sized for trials with a published cap, below the 17,252-participant average among 30 other Polycystic Ovary Syndrome trials with a reported enrollment target (99% lower).

The record links to 1 condition, with Polycystic Ovary Syndrome appearing as the primary indexed condition, and to 2 interventions - of which Inositol supplement is the first listed.

NCT04407754 reports a single indexed study location in Oklahoma.

Frequently Asked Questions

What is clinical trial NCT04407754 about?

NCT04407754 is a clinical study titled "Myo-Inositol for Infertility in PCOS". This will be a prospective, double-blind randomized clinical trial of letrozole and placebo versus letrozole and inositols for up to 5 treatment cycles of ovulation induction or until pregnancy is achieved. All participants and members of the research team will be blinded to the treatment arms. Plac...

What is the current status of trial NCT04407754?

This trial is currently recruiting. It is a NA study. The enrollment target is 168 participants. The study started on 2022-02-07. Estimated completion is 2026-02.

What conditions does trial NCT04407754 study?

This clinical trial studies the following conditions: Polycystic Ovary Syndrome.

What interventions are being tested in trial NCT04407754?

The interventions under investigation include: Inositol supplement (DIETARY_SUPPLEMENT), Placebo supplement (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT04407754?

This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04407754 being conducted?

This trial has 1 study location across Oklahoma. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Polycystic Ovary Syndrome

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04407754's enrollment target sits among peer trials

168 7th of 30 higher than 24 of 30 other Polycystic Ovary Syndrome trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Polycystic Ovary Syndrome trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02118922 · 168 participants

    A Study to Test the Diagnostic Potential of Brillouin Microscopy for Corneal Ectasia

  • NCT03536897 · 168 participants

    IORT Following Breast Conserving Surgery for Early Stage Breast Cancer Registry

  • NCT04078230 · 168 participants · NA

    Regional or Extend LymphAdenectomy During Resection of Intrahepatic Cholangiocarcinoma

  • NCT04159168 · 168 participants · NA

    Facial Affect Sensitivity Training for Young Children With Callous-unemotional Traits

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04407754, the US trial registry maintained by the National Library of Medicine. NCT04407754 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.